amiodarone has been researched along with pirarubicin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedenne, L; Beltramo, JL; Cercueil, JP; Chauffert, B; Cognet, F; Faure, P; Favoulet, P; Isambert, N; Krause, D; Osmak, L | 1 |
| Bedenne, L; Cercueil, JP; Chauffert, B; Ferrant, E; Flesch, M; Isambert, N; Jouve, JL; Krause, D | 1 |
| Bedenne, L; Bonnetain, F; Boulin, M; Cercueil, JP; Chauffert, B; Colin, C; Ferrant, E; Ghiringhelli, F; Guiu, B; Guiu, S; Hillon, P; Jouve, JL; Krause, D; Loffroy, R; Minello, A | 1 |
| Bedenne, L; Bonnetain, F; Boulin, M; Cercueil, JP; Chauffert, B; Ciboulet, A; Gagnaire, A; Guiu, B; Hillon, P; Jouve, JL; Krause, D; Lepage, C; Maillard, E; Minello, A | 1 |
1 trial(s) available for amiodarone and pirarubicin
| Article | Year |
|---|---|
Randomised controlled trial of lipiodol transarterial chemoembolisation with or without amiodarone for unresectable hepatocellular carcinoma.
Topics: Adult; Aged; Amiodarone; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease-Free Survival; Doxorubicin; Ethiodized Oil; Excipients; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Treatment Outcome | 2011 |
3 other study(ies) available for amiodarone and pirarubicin
| Article | Year |
|---|---|
Increased cytotoxicity and stability of Lipiodol-pirarubicin emulsion compared to classical doxorubicin-Lipiodol: potential advantage for chemoembolization of unresectable hepatocellular carcinoma.
Topics: Amiodarone; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chromatography, High Pressure Liquid; Doxorubicin; Drug Resistance, Multiple; Drug Stability; Emulsions; Enzyme Inhibitors; Humans; Iodized Oil; Liver Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2001 |
[Sustained clinical response of large hepatocellular carcinoma after chemoembolization with pirarubicin, amiodarone and Lipiodol].
Topics: alpha-Fetoproteins; Amiodarone; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Doxorubicin; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Injections, Intra-Arterial; Iodized Oil; Liver Neoplasms; Male; Middle Aged | 2004 |
Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Amiodarone; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Female; Humans; Immunosuppressive Agents; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Pilot Projects; Prognosis; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2009 |